secwatch.observer — SEC 8-K summary
======================================

Issuer:     Envista Holdings Corp (NVST)
CIK:        0001757073
Form:       8-K
Filed at:   2025-07-31T23:59:59+00:00
Accession:  0001757073-25-000042
Event type: earnings
Sentiment:  positive
Materiality: 0.85
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Envista Q2 revenue $682M (+5.6% core); raises FY adjusted EPS guidance to $1.05-$1.15
--------------------------------------------------------------------------------

- Q2 net income $26M vs loss of $1,152M a year ago; adjusted EPS $0.26 (+136% YoY).
- Core sales growth 5.6% YoY across all businesses and geographies, including Nobel Biocare in North America.
- FY2025 guidance raised: core sales growth 3-4% (prior 1-3%), adjusted EPS $1.05-$1.15 (prior $0.95-$1.05).
- Repurchased 4.8M shares for ~$82M in Q2; $150M remaining under buyback program.
- YTD operating cash flow $89M, free cash flow $71M, down from $133M and $116M in H1 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1757073/000175707325000042/0001757073-25-000042-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1757073/000175707325000042/nvst-20250731.htm
  HTML page:      https://secwatch.observer/filing/0001757073-25-000042

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer